The Botswana Medicines Regulatory Authority wishes to inform the public of a potential safety issue in Ranitidine containing products. The presence of nitrosamine impurity called N-nitrosodimethylamine (NDMA) has been identified in the products at low levels. NDMA is classified as a possible human carcinogen (a substance that could cause cancer) based on results of animal studies. NDMA is a known environmental contaminant and it is not expected to cause any harm when ingested in low quantities.
Welcome back and Happy New Year
Dear BoMRA Team,Welcome back and Happy New Year! I hope you all had a joyful and restful holiday season.